ClinicalTrials.gg
Status unknownNCT05810454iPACES-PDUpdated Apr 12, 2023

iPACES v3 MCI NIA Protocol Copied for iPACES v4 PD NINDS

An interventional study of iPACES (interactive Physical and Cognitive Exercise System) and PACE (Physical and Cognitive Exercise) in Parkinson's Disease, PD and Mild Cognitive Impairment, sponsored by iPACES LLC. Status unknown at 1 site in United States. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-12.

Sponsored by iPACES LLC · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2023), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

The primary purpose of this study is to attempt to replicate and extend promising pilot findings regarding the cognitive benefits of in-home neuro-exergaming with iPACES (interactive Physical and Cognitive Exercise System v3) for persons with mild cognitive impairment (MCI), to evaluate effects for persons with Parkinson's Disease (PD). Participants will include persons with PD, and potentially, also their co-residing partner, who will exercise at home or accessible location, 3-5 times per week for at least 6 months, with follow-up one month after the main intervention. All participation is "remote" (completed at home, or location of choice), utilizing either one's own equipment ("bring-your-own-devices" BYODs: pedaler, phone/tablet, smart-watch) or some equipment which may be supplied by the grant-funded study and shipped directly to the home; all study measures are completed remotely (e.g., via phone app, website, biometric device, videoconference, email, snail mail, etc.).

Read the detailed description

A specific aim is to evaluate the effects of iPACES for persons with Parkinson's Disease, while also examining the potentially unique contribution of combining mental and physical exercise in an interactive way: "pedal-to-play" (iPACES), as compared with non-interactive, but simultaneous: "pedal-while-play" (PACE).

02

Conditions studied

  • Parkinson's Disease
  • PD
  • Mild Cognitive Impairment
  • MCI

Keywords

  • Parkinson
  • exercise
  • exergame
  • physical activity
  • neuro-exergaming
  • neuropsychological
  • cognitive
  • dual-task
  • interactive
  • executive function
03

In context

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,097 are open to participants now.

This study's planned enrollment of 120 is above the median of 40 across 3,365 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

iPACES LLC is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. 50 years of age or older
  2. meets criteria for MCI (per site staff/MD/neuropsychologist and confirmed by study-administered Montreal Cognitive Assessment; MoCA; score = between 16-26, non-inclusive; Milani, 2018)

4. available for participation for one year (tablet surveys, videoconference evaluations) 5. willing and able to exercise 3-5 times per week for at least 6 months 6. can pedal an under-table elliptical 7. can read off of a small tablet screen 8. proficient in English (speaking and reading for completion of interview, surveys, game); Spanish language option anticipated soon 9. can participate in testing and read and operate tablet touch screen (adequate hearing, vision, speech) 10. written approval from primary care physician and cardiologist (if applicable) to participate in exercise for this study 11. can provide informed consent

Exclusion criteria

Exclusion Criteria:

  1. already exercising at recommended levels (45 min of moderate intensity aerobic exercise 5-7x/wk)
  2. significant history of cardiovascular problems
  3. significant history of stroke
  4. significant history of memory problems (e.g., dementia/Alzheimer's)
  5. significant history of other neurological condition (e.g., seizures, etc.)
  6. significant uncontrolled tremor such that would interfere with touch-screen use required throughout the study (surveys, game-play, etc.)
  7. not prone to cybersickness (e.g., "car sickness" or problems with "screen time")
  8. cannot provide informed consent (i.e., when phone screened with the Impaired Decision Making Capacity screen)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    iPACES (interactive Physical and Cognitive Exercise System)

    iPACES (interactive Physical and Cognitive Exercise System) involves a "pedal-to-play" neuro-exergame in which physical and mental exercise are combined in an interactive way. In this condition a person will pedal to control forward motion in a tablet-based game, such as when pedaling along a virtual path and steering to different assigned errand locations.

    Device: iPACES (interactive Physical and Cognitive Exercise System)

  • Active comparator
    PACE (physical and cognitive exercise)

    PACE (Physical and Cognitive Exercise) involves a "pedal-while-play" experience in which physical and mental exercise are combined in a simultaneous, but not fully interactive way. In this condition a person will pedal while also separately steering in a tablet-based game, such as when pedaling while automatically progressing along a virtual path to different assigned errand locations.

    Device: PACE (Physical and Cognitive Exercise)

Interventions

  • DeviceiPACES (interactive Physical and Cognitive Exercise System)

    iPACES involves a "pedal-to-play" neuro-exergame in which physical and mental exercise are combined in an interactive way. In this condition a person will pedal to control forward motion in a tablet-based game, such as when pedaling along a virtual path and steering to different assigned errand locations.

    Also known as: neuro-exergame

  • DevicePACE (Physical and Cognitive Exercise)

    PACE involves a "pedal-while-play" experience in which physical and mental exercise are combined in a simultaneous, but not fully interactive way. In this condition a person will pedal while also separately steering in a tablet-based game, such as when pedaling while automatically progressing along a virtual path to different assigned errand locations.

06

What researchers measure

Primary outcomes

  1. executive function

    cognitive function composite score from neuropsychological tests (e.g., Stroop); higher scores on the standardized composite would be centered around zero, and higher scores would indicate better performance

    Time frame: change from baseline to 3 months

  2. everyday function

    subjective cognitive function in everyday living (e.g., Ecological Validity Scale); higher scores would indicate better outcomes

    Time frame: change from baseline to 3 months

Secondary outcomes

  1. biomarker

    biomarker (dried blood spot samples; DBSS) linking exercise to cognitive function (e.g., planned analyses include: BDNF/Brain Derived Neurotrophic Factor and IGF-1/Insulin-like Growth Factor)

    Time frame: change from baseline to 3 months

  2. visuospatial function

    cognitive function composite score from neuropsychological tests (e.g., Rey-Osterrieth Complex Figure/ReyO); higher scores would indicate better performance

    Time frame: change from baseline to 3 months

  3. PD-ADLs

    Parkinson's Disease Activities of Daily Living (from the Unified Parkinson's Disease Rating Scale; UPDRS); lower scores would indicate better outcomes

    Time frame: change from baseline to 3 months

07

Study locations

1 site
  • remote trial conducted in-home or nearby, across the USA; via iPACES app/video-conference/mail
    Clifton Park, New York 12065, United States
    • DrVal Clinical Research Coordinator · Contact · support@myipaces.org · 737-747-2237
    • Cay Anderson-Hanley, PhD · Principal investigator
    • Bob Gillen, PhD · Principal investigator
08

References and documents

Publications

  • Wall K, Stark J, Schillaci A, Saulnier ET, McLaren E, Striegnitz K, Cohen BD, Arciero PJ, Kramer AF, Anderson-Hanley C. The Enhanced Interactive Physical and Cognitive Exercise System (iPACESTM v2.0): Pilot Clinical Trial of an In-Home iPad-Based Neuro-Exergame for Mild Cognitive Impairment (MCI). J Clin Med. 2018 Aug 30;7(9):249. doi: 10.3390/jcm7090249. PubMed 30200183 ↗
  • Anderson-Hanley C, Stark J, Wall KM, VanBrakle M, Michel M, Maloney M, Barcelos N, Striegnitz K, Cohen BD, Kramer AF. The interactive Physical and Cognitive Exercise System (iPACES): effects of a 3-month in-home pilot clinical trial for mild cognitive impairment and caregivers. Clin Interv Aging. 2018 Sep 4;13:1565-1577. doi: 10.2147/CIA.S160756. eCollection 2018. PubMed 30233154 ↗
  • Anderson-Hanley C, Barcelos NM, Zimmerman EA, Gillen RW, Dunnam M, Cohen BD, Yerokhin V, Miller KE, Hayes DJ, Arciero PJ, Maloney M, Kramer AF. The Aerobic and Cognitive Exercise Study (ACES) for Community-Dwelling Older Adults With or At-Risk for Mild Cognitive Impairment (MCI): Neuropsychological, Neurobiological and Neuroimaging Outcomes of a Randomized Clinical Trial. Front Aging Neurosci. 2018 May 4;10:76. doi: 10.3389/fnagi.2018.00076. eCollection 2018. PubMed 29780318 ↗
  • Anderson-Hanley C, Arciero PJ, Brickman AM, Nimon JP, Okuma N, Westen SC, Merz ME, Pence BD, Woods JA, Kramer AF, Zimmerman EA. Exergaming and older adult cognition: a cluster randomized clinical trial. Am J Prev Med. 2012 Feb;42(2):109-19. doi: 10.1016/j.amepre.2011.10.016. PubMed 22261206 ↗
  • Anderson-Hanley C, Maloney M, Barcelos N, Striegnitz K, Kramer A. Neuropsychological Benefits of Neuro-Exergaming for Older Adults: A Pilot Study of an Interactive Physical and Cognitive Exercise System (iPACES). J Aging Phys Act. 2017 Jan;25(1):73-83. doi: 10.1123/japa.2015-0261. Epub 2016 Aug 24. PubMed 27337738 ↗

Individual participant data

Plan to share: Yes — de-identified data will be made available in downloadable form

Supporting information: Study protocol, Clinical study report

Time frame: 1-3 years depending upon pace of enrollment

Access criteria: IPD sharing access may be requested at support@myipaces.org

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 12, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05810454
Lead sponsor
iPACES LLC
Collaborators
Pacific Brain Health Center, 1st Playable Productions, Adirondack Neuropsychological Associates, Albany Medical College, Center for Balance, Mobility & Wellness at Gordon College
Responsible party
Sponsor
First posted
Apr 12, 2023
Start date
Aug 2023 (estimated)
Primary completion
Aug 2025 (estimated)
Completion
Aug 2026 (estimated)
Last update
Apr 12, 2023

Study contacts

DrVal Clinical Research Coordinator
Contact
support@myipaces.org
737-747-2237
self-enrollment option www.myipaces.org
Contact
Bob Gillen, PhD
principal investigator · iPACES LLC
Cay Anderson-Hanley, PhD
principal investigator · iPACES LLC

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion